Aug 2026· International Journal on Biological Sciences· Vol 22, pp. 7358 - 7379· 0 citations· 66 references
Medicine
TL;DR
Collectively, exosomal miR-1246 activates HSCs and remodels the stiff ECM to promote liver metastasis, and it may serve as a potential diagnostic and prognostic marker for PDAC liver metastasis.
Abstract
Liver metastasis is a major factor contributing to the poor prognosis of pancreatic ductal adenocarcinoma (PDAC). The formation of pre-metastatic niche (PMN) initiates the process of liver metastasis. Exosomes (Exos) act as key mediators of crosstalk between the tumor microenvironment (TME) and the PMN to activate hepatic stellate cells (HSCs) and remodel the stiff extracellular matrix (ECM). In this study, we isolated Exos derived from PDAC cells cultured under acidic conditions and demonstrated that these Exos significantly activate HSCs and promote the remodeling of the stiff ECM, thereby promoting the stemness, migration, and invasion of PDAC cells. High expression of exosomal miR-1246 was screened by miRNA-sequencing, and Wiskott-Aldrich syndrome protein Family Member 3 (WASF3) was identified as the target of miR-1246. Mechanistically, exosomal miR-1246 activates HSCs to remodel the ECM by targeting WASF3 and stimulating the phosphatidylinositol 3-kinase-serine/threonine protein kinase (PI3K/Akt) pathway. Notably, RNA-binding protein immunoprecipitation (RIP) and miRNA pull-down assays were performed to identify that Human Antigen R (HuR) contributes to the enrichment of miR-1246 into Exos. Collectively, exosomal miR-1246 activates HSCs and remodels the stiff ECM to promote liver metastasis, and it may serve as a potential diagnostic and prognostic marker for PDAC liver metastasis.
Fibroblast-intrinsic p38α MAPK is established as a central regulator of the early PSC-to-CAF transition, coupling inflammatory and tumor-derived signals to chromatin remodeling and sustained stromal activation.
Sayan Chakraborty, C. Acevedo, Samara P. Singh et al.· Cancer Research· 0 citations
OBJECTIVE
Cancer-associated fibroblasts (CAFs) contribute to pancreatic cancer (PC) progression and therapeutic resistance. This study investigated whether CAF-derived exosomes (CAF-exo)-promote PC cell stemness and gemcitabine (GEM) resistance by delivering Snail and regulating the suppressor of cytokine signaling 6/h...
Zhen Luo, Yuqin Hu, Jian Li et al.· Cellular Signalling· 0 citations
Exosomal circ-ZNF652 is associated with TGF-β1-induced mesenchymal phenotype acquisition and glycolysis via the AKT/HIF-1α pathway, promoting HCC progression and represents a potential non-invasive biomarker and therapeutic target for HCC.
Xian-Li Niu, Xiao-Min Zhang, Guang-Xia Liang et al.· Journal of Microbiology and...· 0 citations
Findings identify SFRP2 as a key regulator of PDAC progression and support the development of SFRP2-targeted therapies as a novel treatment strategy for pancreatic cancer.
Olivia Sweatt, Lillian Hsu, Lety Reyes Angeles et al.· Cancer Research· 0 citations
It was demonstrated that CAF-derived EVs enhanced the proliferative, migratory and invasive capacity of PDAC cells across two independent cell lines, as assessed by Cell Counting Kit-8 assays and Transwell migration and Matrigel invasion assays.
Daigo Yoshimori, M. Kudo, Kousuke Ishino et al.· Oncology Report· 0 citations
This work identified p38α MAPK (p38α; MAPK14) as a key regulator of inflammatory CAF activation and collagen remodeling and implicates it as a central mediator of stromal remodeling and therapeutic resistance in pancreatic cancer.
C. Acevedo, Sayan Chakraborty, Samara P. Singh et al.· Cancer Research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.